Chief Medical Officer
Jane Tiller, MBChB, FRCPsych, MPhil, MBA is a senior executive who combines scientific, medical and business expertise to effectively manage high performing clinical organizations and lead all facets of drug development from clinical research to medical affairs.
Jane has fourteen years of experience leading pharmaceutical medical organizations across multiple therapeutic areas (neuroscience, immunology, virology, cardiovascular, immune-oncology, sleep medicine and pain) in the US and Europe, including multiple product launches. Her industry roles have included Head of Medical for Europe, Australia and Canada and Development Team Leader (Alzheimer’s) at Bristol Myers Squibb and VP of Clinical Development CNS/Pain at Cephalon. She has experience of small and large molecule development and as well as development of diagnostics.
Jane’s deep understanding of health care dynamics, behavioral health technologies and physician and patient is needs informed by 17 years of clinical and academic medical practice, including 5 as Clinical Director at the Maudsley Hospital London.
She is a highly effective leader, dedicated to building and developing talent and helping teams navigate complex realities. Energetic, strategic and collaborative, she excels at working across diverse groups to get things done.